三磷酸腺苷或腺苷对心律失常的诊疗作用

中国临床药理学与治疗学 ›› 2002, Vol. 7 ›› Issue (2): 184-188.

三磷酸腺苷或腺苷对心律失常的诊疗作用

何胜虎综述, 曹克将¹, 单其俊¹ 审校

扬州大学临床医学院心内科, 扬州 225001;
¹南京医科大学第一附属医院心内科, 南京 210019

收稿日期:2001-07-31 修回日期:2001-08-28 出版日期:2002-04-26 发布日期:2020-11-27
通讯作者: 何胜虎, 男, 硕士, 心内科副主任, 副教授, 主要从事心脏介入治疗工作。
作者简介:曹克将, 男, 博士, 心内科主任, 教授, 博士生导师, 研究方向:介入心脏病学、电生理及射频消融。Tel:0514-7977557 　E-mail:yzhesh @pub.jsinfo.net

Advance in diagnosis and treatment of arrhythmia by adenosine triphosphate or adenosine

HE Sheng-Hu, CAO Ke-Jiang¹, SHAN Qi-Jun¹

Department of Cardiology, Clinical Medical Institute of YangzhuoUniversity, Yangzhuo 225001;
¹Department of Cardiology,The First Affiliated Hospital of Nanjing Medical University, Nanjing 210019

Received:2001-07-31 Revised:2001-08-28 Online:2002-04-26 Published:2020-11-27

摘要/Abstract

摘要： 三磷酸腺苷或腺苷是临床诊疗心律失常的一种重要方法, 它可终止阵发性室上性心动过速, 终止特殊类型室速, 对多种类型的心律失常有鉴别诊断作用。另外, 三磷酸腺苷或腺苷对窦房结功能障碍也有诊断价值, 还可应用于射频导管消融术。

关键词: 三磷酸腺苷, 腺苷, 心律失常, 电生理

Abstract: Administration of adenosine triphosphate or adenosine is an important clinical trial in diagnosis and treatment of arrhythmias.It may not only terminate the paroxysmal supraventricular tachycardia and the specific type of ventricular tachycardia, but also identify the mechanism of majority of arrhythmias.Otherwise, It is also a useful diagnostic test for sick sinus sydrome and a reliable methos to assess radiofrequency catheter ablation.

Key words: adenosine triphosphate, adenosine, arrhythmia, electrophysiology

中图分类号:

R972.

何胜虎, 曹克将, 单其俊. 三磷酸腺苷或腺苷对心律失常的诊疗作用[J]. 中国临床药理学与治疗学, 2002, 7(2): 184-188.

HE Sheng-Hu, CAO Ke-Jiang, SHAN Qi-Jun. Advance in diagnosis and treatment of arrhythmia by adenosine triphosphate or adenosine[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2002, 7(2): 184-188.

参考文献

1 Salvator CA, Jacobson KA, Taylor HE, et al.Molecular cloning and characterization of the human A3 receptor[J].JMed Chem, 1993;90:10356-9
2 Haleen SJ, Evans DB.Electively effects of adenosine receptor agonists upon coronary resistance and heart rate in isolated working rabbit hearts[J].Life Sci, 1985;36:127-37
3 Dimarco JP, Miles W, Akhtar M, et al.Adenosine for paroxysmal supraventricular tachycardia:dose ranging and comparation with verapamil[J].Ann Intern Med, 1996;113:104-10
4 张海澄, 郭继鸿, 许原, 等.三磷酸腺苷对房室旁路和房室结传导的影响[J].中华心律失常学杂志, 1999;2:110-2
5 Curits AB, Belardinelli L,Woodard DA, et al.Induction of atrioventricular node reentrent tachycardia with adenosine:differential effect of adenosine on fast and slow atrioventricular node pathway[J].J Am Coll, 1997;30:1778-84
6 金华, 郭继鸿, 许原, 等.三磷酸腺苷对房室结前向传导的影响与房室结前传功能的相关性研究[J].中华心血管病杂志, 1999;27:447-9
7 Lerman BB, Belardinelli L,West GA, et al.Adenosine-sensitive ventricular tachycardia:evidence suggesting cy clic AMP-mediated triggered activity[J].Circulation, 1986;74:270-80
8 Griffth MJ, Linker NJ, Ward DE, et al.Adenosine in the diagnosis of broad complex tachycardias[J].Br Heart J, 1989;62: 195-203
9 Dimarco JP, Seller TD, Lerman BB, et al.Diagnostic and therapeutic use of adenosine in pations with paroxysmal supraventricular tachycardia[J].J Am Coll Cardiol, 1985;6:417-225
10 Bellhassen B, Glick A, Laniado S.Comparative clinical and electrophysiologic effects on adenosive triphosphate and verapamil on paroxysmal reciprocating junctional tachycardia[J]. Circulation, 1988;77:795-805
11 Bellhassen B, Fish R, Glikson M, et al.Noninvasive diagnosis of dual AV node physiology in patiens with AV nodal reentrent tachycardia by administration of adenosine-5'-triphosphate during sinus rhythm[J].Circulation, 1998;98:47-53
12 Rankin AC, Oldryd KG, Chong E, et al.Value and limitation of adenosine in the diagnosis and treatment of narrow and broad complex tachy cardias[J].Br Heart J, 1989;62:195-203
13 Till J, Shinhourne EA, Rigby ML, et al.Efficacy and safety of adenosine in the treatment of supraventricular tachycardia in infants and children[J].Br Heart J, 1989;62:204-301
14 Garratt CJ, Antoniou A, Griffth MJ, et al.Use of adenosine in sinus rhythm as a diagnostic test for latent preexcitation[J].Am J Cardiol, 1990;65:868-73
15 Lerman BB, Greenberg M, Overholt EB, et al.Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia[J].Circulation, 1987;76:21-31
16 Camm AJ, Garrat CJ.Adenosine and supraventricular tachycardia[J].N Eng J Med, 1991;325:1621-9
17 Burnett D, Abisamra F, Vacek JL.The use of intravenous adenosine as a noinvasive diagnostic test for sick sinus syndrome [J].Circulation, 1996;94(suppl 1):I-627
18 Keim S, Curtis AB, Belardinelli L, et al.Adenosine induced atrioventricular block:a rapid and reliable method to assess surgical and radiofrequency catheter ablation of accessory atrioventricular pathways[J].J Am Coll Cardiol, 1992;19:1005-11
19 Souza JJ, Zivin A, Flemming M, et al.Differential effect of adenosine on anterograde fast pathway conduction in patients with atrioventricular nodal reentrant tachycardia[J].J Cardiovas Electrophysiol, 1998;9:820-4
20 Shama AD, Klein GJ, Yee R.Intravenous adenosine triphosphate during wide QRS complex tachycardia:safe, therapeutic efficacy and diagnostic utility[J].Am J Med, 1990;88:337-43
21 Iesak Y, Takahashi A, Goya M, et al.Adenosine-sesitive atrial reentrant tachycardia originating from the artrioventricular nodal transitional area[J].J Cardiovas Electrophysiol, 1997;8:854-64
22 Miyata A, Kobayashi Y, Jinbo Y, et al.Effects of adenosine triphosphate on ventriculoatrial conduction-usefulness and problems in assessment of catheter ablation of accessory pathways [J].Jpn Circ J, 1997;62:323-30
23 Wilbur SL, Marchlinski FE.Adenosine as antiarrhythmia agent [J].Am J Cardiol, 1997;79:30-7
24 Rankin AC, Brooks R, Ruskin JN, et al.Adenosine and the treatment of supraventricular tachycardia[J].Am JMed, 1992; 92:655-8
25 Glatter KA, Cheng J, Dorostkar P, et al.Electrophysiologic effects of adenosine in patients with supraventricular tachycardia [J].Circulation, 1999;99:1034-40
26 Rankin AC, Rae AP, Houston A.Acceleration of ventricular response to atrial flutter after intravenous adenosine[J].Br Heart J, 1993;69:263-5

[1]	张志英, 靳秀红, 张小宁, 张向峰, 罗青林, 张松林. TBX21和ADCY9多态性在儿童哮喘发生发展中的临床研究[J]. 中国临床药理学与治疗学, 2023, 28(4): 407-412.
[2]	张华斌, 罗中旭, 钟民, 洪宗元, 王德国. 脊髓麻醉对大鼠急性心肌缺血再灌注室性心律失常的影响研究[J]. 中国临床药理学与治疗学, 2023, 28(3): 249-256.
[3]	徐润泽, 韩静静, 李文倩, 杨劲. 从非临床到临床心律失常风险阶段评估体系研究进展[J]. 中国临床药理学与治疗学, 2021, 26(4): 423-433.
[4]	赵芳卿, 杨雯雯, 殷玉杰, 张斌, 王邦才, 窦晓兵, 李松涛, 朱林文思. 丹酚酸A激活AMPK及SIRT1减轻棕榈酸诱导的肝细胞脂毒性[J]. 中国临床药理学与治疗学, 2021, 26(3): 241-249.
[5]	陈树儒, 路荣忠, 杜冠华, 赵玉军, 杨新博. 天然心房肽抗心律失常病例报道与机制分析[J]. 中国临床药理学与治疗学, 2021, 26(10): 1213-1214.
[6]	陈力方, 王博, 王维蓉. 组蛋白去乙酰化酶3在心血管疾病中的研究进展[J]. 中国临床药理学与治疗学, 2021, 26(1): 88-97.
[7]	夏洪莲, 钟微微, 金鹏, 陈猛, 刘再英, 张艳丽. PI3K/AKT/GSK3β信号通路参与腺苷A1R介导异丙酚对缺血再灌注损伤大鼠的脑保护作用[J]. 中国临床药理学与治疗学, 2020, 25(12): 1344-1350.
[8]	全海燕，刘玉环，杨丽，阳芳，秦旭平. CGRP通过激活cAMP/PPARγ/eNOS途径改善血管内皮细胞胰岛素抵抗[J]. 中国临床药理学与治疗学, 2019, 24(6): 615-622.
[9]	陈峰，邹懿，胡波，胡松，陈勇，高大新. 鼠神经生长因子对坐骨神经痛大鼠背根神经节磷酸化p38MAPK表达的影响[J]. 中国临床药理学与治疗学, 2019, 24(4): 411-417.
[10]	官俏兵，韩晨阳，储志远，杨毅，张晓玲. 丁苯酞通过激动cAMP/CREB/BDNF信号通路改善小鼠缺血再灌注后认知障碍的作用机制[J]. 中国临床药理学与治疗学, 2019, 24(2): 152-157.
[11]	陈瑜，殷为勇，陈艳艳，朱振国，郑荣远，郑浏璞. 腺苷A2AR拮抗剂对中枢炎症性小胶质细胞形态和功能的影响[J]. 中国临床药理学与治疗学, 2019, 24(12): 1376-1384.
[12]	周水妹，瞿伟，姚建标，徐露. 原花青素对AD大鼠学习记忆及CREB蛋白表达的影响[J]. 中国临床药理学与治疗学, 2017, 22(6): 650-653.
[13]	蒙国懿，何繁漪，隋念含，赵林波，洪仕君，邢豫明，赵永娜. RGS4和D2受体信号通路相关分子在甲基苯丙胺依赖CPP大鼠纹状体的表达变化[J]. 中国临床药理学与治疗学, 2017, 22(12): 1377-1381.
[14]	夏洪莲，韩琨元，王丹丹，戴勤学，王均炉. 腺苷A1受体介导异丙酚预处理对局灶性脑缺血再灌注损伤大鼠的缺血耐受[J]. 中国临床药理学与治疗学, 2016, 21(4): 389-394.
[15]	何胜虎，周胜华，张晶,王雪飞,王大新. 急性ST段抬高型心肌梗死急诊PCI发生恶性心律失常临床特点及替罗非班的影响[J]. 中国临床药理学与治疗学, 2016, 21(4): 432-435.